Featured Research

from universities, journals, and other organizations

Advanced pancreatic cancer: Phase I drug study underway

Date:
June 3, 2014
Source:
University of Illinois at Chicago
Summary:
A clinical trial to evaluate a new, three-drug combination therapy for advanced pancreatic cancer is underway. Pancreatic ductal carcinoma has a five-year survival rate of less than 5 percent and is the fourth-leading cause of cancer death in the U.S., claiming nearly 40,000 lives each year. Scientists have made some progress in the last decade to understand the biology of the disease at the cellular level, but advances in clinical outcomes have not kept pace.

Researchers at the University of Illinois at Chicago are conducting a clinical trial to evaluate a new, three-drug combination therapy for advanced pancreatic cancer.

Related Articles


Pancreatic ductal carcinoma has a five-year survival rate of less than 5 percent and is the fourth-leading cause of cancer death in the U.S., claiming nearly 40,000 lives each year.

Scientists have made some progress in the last decade to understand the biology of the disease at the cellular level, but advances in clinical outcomes have not kept pace.

"There is an urgent and unmet need for effective treatments for patients with advanced pancreatic cancer after first-line chemotherapy fails," said Dr. Neeta Venepalli, UIC assistant professor of hematology and principal investigator of the study.

Patients in the phase 1 study will be given three drugs that are thought to attack the cancer cells in different ways. One, gemcitabine, is an FDA-approved chemotherapy drug that works by slowing or stopping the growth of tumors. It has been the standard treatment for advanced pancreatic cancer for the past decade.

A second drug, a monoclonal antibody that recognizes a protein called mucin 1 that prevents the death of cancer cells and is overabundant in pancreatic ductal carcinoma, is given to patients to stimulate an immune response. The antibody also attracts the third drug, Imprime PGG, which travels to the tumor site to activate an immune response and kill targeted cancer cells.

"Our phase 1 trial combines gemcitabine with two novel cancer immunotherapies -- a regimen that has not been tried before," said Venepalli, a member of the UI Cancer Center.

"We are optimistic and excited about providing a new approach to treating this devastating disease."

The study will evaluate the drug combination to determine the highest dose of the monoclonal antibody that can be tolerated without unacceptable side effects.


Story Source:

The above story is based on materials provided by University of Illinois at Chicago. The original article was written by Sherri McGinnis Gonzαlez. Note: Materials may be edited for content and length.


Cite This Page:

University of Illinois at Chicago. "Advanced pancreatic cancer: Phase I drug study underway." ScienceDaily. ScienceDaily, 3 June 2014. <www.sciencedaily.com/releases/2014/06/140603162016.htm>.
University of Illinois at Chicago. (2014, June 3). Advanced pancreatic cancer: Phase I drug study underway. ScienceDaily. Retrieved January 30, 2015 from www.sciencedaily.com/releases/2014/06/140603162016.htm
University of Illinois at Chicago. "Advanced pancreatic cancer: Phase I drug study underway." ScienceDaily. www.sciencedaily.com/releases/2014/06/140603162016.htm (accessed January 30, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, January 30, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC: Get Vaccinated for Measles

CDC: Get Vaccinated for Measles

Reuters - US Online Video (Jan. 30, 2015) — The CDC is urging people to get vaccinated for measles amid an outbreak that began at Disneyland and has now infected more than 90 people. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Obama To Outline New Plan For Personalized Medicine

Obama To Outline New Plan For Personalized Medicine

Newsy (Jan. 30, 2015) — President Obama is expected to speak with drugmakers Friday about his Precision Medicine Initiative first introduced last week. Video provided by Newsy
Powered by NewsLook.com
Oxfam Calls for Massive Aid for Ebola-Hit West Africa

Oxfam Calls for Massive Aid for Ebola-Hit West Africa

AFP (Jan. 29, 2015) — Oxfam International has called for a multi-million dollar post-Ebola "Marshall Plan", with financial support given by wealthy countries, to help Guinea, Sierra Leone and Liberia to recover. Duration: 01:10 Video provided by AFP
Powered by NewsLook.com
Are We Winning The Fight Against Ebola?

Are We Winning The Fight Against Ebola?

Newsy (Jan. 29, 2015) — The World Health Organization announced the fight against Ebola has entered its second phase as the number of cases per week has steadily dropped. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins